发明名称 PYRIMIDINYL TYROSINE KINASE INHIBITORS
摘要 The present invention provides compounds and compositions thereof which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same.
申请公布号 US2016304494(A1) 申请公布日期 2016.10.20
申请号 US201615196389 申请日期 2016.06.29
申请人 Biogen MA Inc. ;Sunesis Pharmaceuticals, Inc. 发明人 Hopkins Brian T.;Chan Timothy R.;Jenkins Tracy J.;Conlon Patrick;Cai Xiongwei;Humora Michael;Shi Xianglin;Miller Ross A.;Thompson Andrew
分类号 C07D401/14 主分类号 C07D401/14
代理机构 代理人
主权项 1. A compound of formula I:or a pharmaceutically acceptable salt thereof,wherein: each R1 is independently hydrogen, an optionally substituted C1-6 aliphatic group, an optionally substituted 3-7 membered monocyclic heterocyclic group, or an optionally substituted heterocyclylalkyl group having 3-7 carbon atoms and 1-3 heteroatoms independently selected from nitrogen, oxygen, or sulfur; or two R1 groups are taken together with their intervening atoms to form an optionally substituted 3-7 membered saturated or partially unsaturated monocyclic heterocyclic ring having 1-2 heteroatoms independently selected from nitrogen, oxygen, or sulfur; wherein optionally substituted groups may be substituted with halogen, —NO2, —CN, —OR, —SR, —N(R)2, —C(O)R, —CO2R, —N(R)C(O)OR, —C(O)N(R)2, —OC(O)R, —N(R)C(O)R, —S(O)R, —S(O)2R, or —S(O)2N(R)2; each R is independently hydrogen or C1-6 aliphatic; or two R groups attached to the same nitrogen are taken together with their intervening atoms to form an optionally substituted 3-7 membered saturated or partially unsaturated monocyclic heterocyclic ring having 1-2 heteroatoms, in which any second heteroatom is independently selected from nitrogen, oxygen, or sulfur;Ring A isR2 is —Cl or —F; andR3 is —CF3, —OCF3, or —F.
地址 Cambridge MA US